Viatris Inc

This committee provides the official revenue estimates and technical analysis for all tax legislation. Its work directly influences corporate tax structures, incentives for R&D, and the overall tax burden on Viatris, impacting its financial performance and capital allocation.

This powerful committee controls taxation, trade, and entitlement spending. Its policies on corporate taxes, international trade (affecting global supply chains), and Medicare/Medicaid drug pricing directly impact Viatris's profitability, market access, and overall valuation.

This committee allocates federal discretionary spending. Its decisions directly impact funding for healthcare programs (e.g., NIH research, VA health services, Medicare/Medicaid) which are major purchasers or influencers of Viatris's pharmaceutical products and R&D environment.

This committee directly oversees the FDA, which regulates Viatris's drug approval processes, manufacturing, and market access. Its decisions on healthcare policy and labor laws are fundamental to Viatris's operations and market success.

This committee oversees antitrust laws and intellectual property. For a pharmaceutical company like Viatris, patent litigation, market exclusivity, and antitrust scrutiny are critical to its business model, directly impacting competition and market entry.